Laurence A. Turka, Chief Scientific Officer at Rubius Therapeutics, Inc. (RUBY), sold 2,517 shares at $6.57 ($17K) on 2022-02-01, disclosed to the SEC on 2022-02-01.
Open-market sale of $17k RUBY by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.